vs
肯纳金属（KMT）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
肯纳金属的季度营收约是PHIBRO ANIMAL HEALTH CORP的1.4倍（$529.5M vs $373.9M），PHIBRO ANIMAL HEALTH CORP净利率更高（7.3% vs 6.4%，领先0.9%），PHIBRO ANIMAL HEALTH CORP同比增速更快（20.9% vs 9.8%），肯纳金属自由现金流更多（$42.4M vs $8.3M），过去两年PHIBRO ANIMAL HEALTH CORP的营收复合增速更高（19.2% vs 1.3%）
肯纳金属是高性能切削工具及工程部件制造商，产品广泛应用于航空航天、国防、交通运输、油气钻探等领域，业务覆盖全球市场，为各行业客户提供适配高要求作业场景的专业解决方案。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
KMT vs PAHC — 直观对比
营收规模更大
KMT
是对方的1.4倍
$373.9M
营收增速更快
PAHC
高出11.1%
9.8%
净利率更高
PAHC
高出0.9%
6.4%
自由现金流更多
KMT
多$34.2M
$8.3M
两年增速更快
PAHC
近两年复合增速
1.3%
损益表 — Q2 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $529.5M | $373.9M |
| 净利润 | $33.9M | $27.5M |
| 毛利率 | 32.8% | 35.5% |
| 营业利润率 | 9.9% | 13.5% |
| 净利率 | 6.4% | 7.3% |
| 营收同比 | 9.8% | 20.9% |
| 净利润同比 | 89.0% | 762.1% |
| 每股收益（稀释后） | $0.44 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTPAHC
| Q4 25 | $529.5M | $373.9M | ||
| Q3 25 | $498.0M | $363.9M | ||
| Q2 25 | $516.4M | $378.7M | ||
| Q1 25 | $486.4M | $347.8M | ||
| Q4 24 | $482.1M | $309.3M | ||
| Q3 24 | $481.9M | $260.4M | ||
| Q2 24 | $543.3M | $273.2M | ||
| Q1 24 | $515.8M | $263.2M |
净利润KMTPAHC
| Q4 25 | $33.9M | $27.5M | ||
| Q3 25 | $23.3M | $26.5M | ||
| Q2 25 | $21.6M | $17.2M | ||
| Q1 25 | $31.5M | $20.9M | ||
| Q4 24 | $17.9M | $3.2M | ||
| Q3 24 | $22.1M | $7.0M | ||
| Q2 24 | $37.2M | $752.0K | ||
| Q1 24 | $19.0M | $8.4M |
毛利率KMTPAHC
| Q4 25 | 32.8% | 35.5% | ||
| Q3 25 | 31.0% | 32.9% | ||
| Q2 25 | 28.2% | 29.0% | ||
| Q1 25 | 32.1% | 30.1% | ||
| Q4 24 | 30.1% | 32.9% | ||
| Q3 24 | 31.3% | 32.1% | ||
| Q2 24 | 31.5% | 31.9% | ||
| Q1 24 | 29.7% | 30.2% |
营业利润率KMTPAHC
| Q4 25 | 9.9% | 13.5% | ||
| Q3 25 | 7.5% | 14.1% | ||
| Q2 25 | 6.1% | 8.9% | ||
| Q1 25 | 9.1% | 9.6% | ||
| Q4 24 | 6.6% | 8.3% | ||
| Q3 24 | 7.5% | 6.8% | ||
| Q2 24 | 11.3% | 6.7% | ||
| Q1 24 | 6.8% | 7.6% |
净利率KMTPAHC
| Q4 25 | 6.4% | 7.3% | ||
| Q3 25 | 4.7% | 7.3% | ||
| Q2 25 | 4.2% | 4.5% | ||
| Q1 25 | 6.5% | 6.0% | ||
| Q4 24 | 3.7% | 1.0% | ||
| Q3 24 | 4.6% | 2.7% | ||
| Q2 24 | 6.8% | 0.3% | ||
| Q1 24 | 3.7% | 3.2% |
每股收益（稀释后）KMTPAHC
| Q4 25 | $0.44 | $0.67 | ||
| Q3 25 | $0.30 | $0.65 | ||
| Q2 25 | $0.28 | $0.43 | ||
| Q1 25 | $0.41 | $0.51 | ||
| Q4 24 | $0.23 | $0.08 | ||
| Q3 24 | $0.28 | $0.17 | ||
| Q2 24 | $0.47 | $0.02 | ||
| Q1 24 | $0.24 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.3M | $74.5M |
| 总债务越低越好 | $597.2M | $624.2M |
| 股东权益账面价值 | $1.3B | $332.4M |
| 总资产 | $2.6B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.45× | 1.88× |
8季度趋势，按日历期对齐
现金及短期投资KMTPAHC
| Q4 25 | $129.3M | $74.5M | ||
| Q3 25 | $103.5M | $85.3M | ||
| Q2 25 | $140.5M | $77.0M | ||
| Q1 25 | $97.5M | $70.4M | ||
| Q4 24 | $121.2M | $67.1M | ||
| Q3 24 | $119.6M | $89.8M | ||
| Q2 24 | $128.0M | $114.6M | ||
| Q1 24 | $92.1M | $98.7M |
总债务KMTPAHC
| Q4 25 | $597.2M | $624.2M | ||
| Q3 25 | $597.0M | $628.0M | ||
| Q2 25 | $596.8M | $631.7M | ||
| Q1 25 | $596.6M | $635.4M | ||
| Q4 24 | $596.4M | $639.1M | ||
| Q3 24 | $596.2M | $295.2M | ||
| Q2 24 | $596.0M | $312.1M | ||
| Q1 24 | $595.8M | — |
股东权益KMTPAHC
| Q4 25 | $1.3B | $332.4M | ||
| Q3 25 | $1.3B | $311.7M | ||
| Q2 25 | $1.3B | $285.7M | ||
| Q1 25 | $1.2B | $266.0M | ||
| Q4 24 | $1.2B | $246.8M | ||
| Q3 24 | $1.3B | $258.5M | ||
| Q2 24 | $1.2B | $256.6M | ||
| Q1 24 | $1.3B | $270.1M |
总资产KMTPAHC
| Q4 25 | $2.6B | $1.4B | ||
| Q3 25 | $2.5B | $1.4B | ||
| Q2 25 | $2.5B | $1.4B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.4B | $1.3B | ||
| Q3 24 | $2.5B | $966.3M | ||
| Q2 24 | $2.5B | $982.2M | ||
| Q1 24 | $2.5B | $979.0M |
负债/权益比KMTPAHC
| Q4 25 | 0.45× | 1.88× | ||
| Q3 25 | 0.46× | 2.01× | ||
| Q2 25 | 0.46× | 2.21× | ||
| Q1 25 | 0.48× | 2.39× | ||
| Q4 24 | 0.49× | 2.59× | ||
| Q3 24 | 0.47× | 1.14× | ||
| Q2 24 | 0.48× | 1.22× | ||
| Q1 24 | 0.47× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.1M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | $42.4M | $8.3M |
| 自由现金流率自由现金流/营收 | 8.0% | 2.2% |
| 资本支出强度资本支出/营收 | 2.4% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.63× | 0.70× |
| 过去12个月自由现金流最近4个季度 | $99.3M | $47.3M |
8季度趋势，按日历期对齐
经营现金流KMTPAHC
| Q4 25 | $55.1M | $19.4M | ||
| Q3 25 | $17.5M | $9.3M | ||
| Q2 25 | $78.6M | $21.3M | ||
| Q1 25 | $28.8M | $43.2M | ||
| Q4 24 | $55.2M | $3.1M | ||
| Q3 24 | $45.7M | $12.6M | ||
| Q2 24 | $113.6M | $28.4M | ||
| Q1 24 | $75.2M | $11.4M |
自由现金流KMTPAHC
| Q4 25 | $42.4M | $8.3M | ||
| Q3 25 | $-5.5M | $-4.5M | ||
| Q2 25 | $57.1M | $8.1M | ||
| Q1 25 | $5.3M | $35.4M | ||
| Q4 24 | $35.9M | $-4.7M | ||
| Q3 24 | $21.0M | $3.0M | ||
| Q2 24 | $90.3M | $15.4M | ||
| Q1 24 | $48.4M | $1.7M |
自由现金流率KMTPAHC
| Q4 25 | 8.0% | 2.2% | ||
| Q3 25 | -1.1% | -1.2% | ||
| Q2 25 | 11.1% | 2.1% | ||
| Q1 25 | 1.1% | 10.2% | ||
| Q4 24 | 7.5% | -1.5% | ||
| Q3 24 | 4.4% | 1.2% | ||
| Q2 24 | 16.6% | 5.6% | ||
| Q1 24 | 9.4% | 0.6% |
资本支出强度KMTPAHC
| Q4 25 | 2.4% | 3.0% | ||
| Q3 25 | 4.6% | 3.8% | ||
| Q2 25 | 4.2% | 3.5% | ||
| Q1 25 | 4.8% | 2.2% | ||
| Q4 24 | 4.0% | 2.5% | ||
| Q3 24 | 5.1% | 3.7% | ||
| Q2 24 | 4.3% | 4.8% | ||
| Q1 24 | 5.2% | 3.7% |
现金转化率KMTPAHC
| Q4 25 | 1.63× | 0.70× | ||
| Q3 25 | 0.75× | 0.35× | ||
| Q2 25 | 3.64× | 1.24× | ||
| Q1 25 | 0.92× | 2.07× | ||
| Q4 24 | 3.08× | 0.97× | ||
| Q3 24 | 2.07× | 1.81× | ||
| Q2 24 | 3.06× | 37.80× | ||
| Q1 24 | 3.96× | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMT
| Metal Cutting | $331.1M | 63% |
| Infrastructure | $198.5M | 37% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
